RL
RLLVF.US Relevium Technologies Inc
- Market cap
- USD 1.98M
- P/E
- -
- P/B
- 233.67x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Mar 2022.
Is RLLVF.US undervalued?
Graham numberThe Graham number of Relevium Technologies Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Relevium Technologies Inc fundamental analysis
No fundamental analysis for Relevium Technologies Inc yet.
Relevium Technologies Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Relevium Technologies Inc
Relevium Technologies Inc. engages in the identification, evaluation, acquisition, and operation of brands and businesses in the health and wellness markets with a focus on e-commerce. The company markets dietary supplements, nutraceuticals, sports nutrition products, and cosmeceuticals primarily through its Bioganix brand portfolio online; dietary supplements under the LeefyLyfe brand; and skin care products under the Push & Pull System brand. It also provides Relevium Seni…
Full company profileRelevium Technologies Inc financial statements
2022 annualized: Fiscal year 2022 is not finished. Income statement and cash flow are annualized from 3 quarters up to Mar 31, 2022, the balance sheet is the latest quarter. Figures change when the annual report is published.
Relevium Technologies Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | - | 55.8K | 0.00 | 0.00 | 0.00 | 4.15M | 3.63M | 2.97M | 914K | - |
| Gross Profit | - | 31.3K | 0.00 | -61.9K | -55.7K | 2.28M | 1.77M | 1.19M | 414K | - |
| Operating Income | -239K | -231K | -215K | -797K | -1.39M | -1.99M | -2.47M | -2.77M | -1.48M | - |
| EBITDA | -237K | -219K | -215K | -736K | -1.33M | -1.95M | -3.18M | -6.36M | -4.61M | - |
| Net Income | -238K | -219K | -193K | -1.20M | -1.99M | -2.89M | -3.73M | -6.93M | -5.37M | - |
| EPS | -0.03 | -0.04 | -0.03 | -0.04 | -0.06 | -0.04 | -0.03 | -0.04 | -0.03 | - |
| Balance Sheet | ||||||||||
| Total Assets | 628K | 454K | 384K | 773K | 5.48M | 6.52M | 8.56M | 4.33M | 759K | 3.02M |
| Total Liabilities | 68.3K | 113K | 237K | 344K | 4.17M | 2.64M | 3.51M | 4.28M | 5.66M | 4.16M |
| Shareholders' Equity | 560K | 341K | 147K | 429K | 1.30M | 3.88M | 5.05M | 55.5K | -4.90M | -1.14M |
| Cash & Short-term Investments | 551K | 139K | 57.2K | 40.1K | 700K | 1.58M | 880K | 200K | 69.3K | 586K |
| Total Debt | - | - | - | 49.8K | 3.20M | 2.18M | 2.75M | 2.81M | 3.20M | 1.47M |
| Cash Flow | ||||||||||
| Operating Cash Flow | -128K | -199K | -95.5K | -751K | -993K | -2.36M | -3.21M | -2.16M | -128K | -254K |
| Capital Expenditure | 0.00 | 0.00 | 333.05 | 45.6K | 1.96M | 84.3K | 208K | 4.20K | 0.00 | 0.00 |
| Free Cash Flow | -128K | -199K | -95.5K | -797K | -2.95M | -2.45M | -3.42M | -2.17M | -128K | - |
| Ratios | ||||||||||
| ROE | -42.5% | -64.2% | -131.3% | -279.8% | -152.6% | -74.5% | -73.8% | -12,484.5% | - | - |
| ROA | -37.8% | -48.3% | -50.4% | -155.2% | -36.3% | -44.4% | -43.5% | -159.9% | -707.4% | - |
| Net Profit Margin | - | -392.7% | - | - | - | -69.7% | -102.7% | -233.1% | -587.6% | - |
| Debt to Equity | - | - | - | 0.12x | 2.46x | 0.56x | 0.54x | 50.63x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Relevium Technologies Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2021 | - | - | - |
| 2020 | USD 1.00 | 0.00 | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
| 2016 | - | - | - |
| 2015 | - | - | - |
| 2014 | - | - | - |
| 2013 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Relevium Technologies Inc
- Insiders 3.22%
- Institutions 0.00%
- Public & others 96.78%
- Shares outstanding 329M
- Free float 319M
Relevium Technologies Inc company profile
- Company name
- Relevium Technologies Inc
- Ticker
- RLLVF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Consumer Staples Distribution & Retail
- Fiscal year end
- June
- Address
- 1000 Sherbrooke St. West, Montreal, QC, Canada, H3A 3G4
- Phone
- 888 528 8687
- Website
- releviumtechnologies.com
About Relevium Technologies Inc
Relevium Technologies Inc. engages in the identification, evaluation, acquisition, and operation of brands and businesses in the health and wellness markets with a focus on e-commerce. The company markets dietary supplements, nutraceuticals, sports nutrition products, and cosmeceuticals primarily through its Bioganix brand portfolio online; dietary supplements under the LeefyLyfe brand; and skin care products under the Push & Pull System brand. It also provides Relevium Senior, a geriatric brand targeting inflammatory conditions, including joints, heart, and brain; and Relevium Kids, a pediatric brand of nutraceuticals and oral nutritional supplements. The company was formerly known as BIOflex Technologies Inc. and changed its name to Relevium Technologies Inc. in December 2015. Relevium Technologies Inc. is headquartered in Montreal, Canada.
Relevium Technologies Inc management
3- Mr. Aurelio Useche C.M.A., M.B.A.President, CEO & Director · born 1968
- Mr. Mark Anthony Billings C.F.A., M.B.A.Chief Financial Officer · born 1970
- Mr. Abis HussainSenior Marketing Officer